| 000 | 01592 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516070906.0 | ||
| 264 | 0 | _c20120326 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1090-2430 | ||
| 024 | 7 |
_a10.1016/j.expneurol.2011.11.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSantos, Danúbia B | |
| 245 | 0 | 0 |
_aProbucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice. _h[electronic resource] |
| 260 |
_bExperimental neurology _cFeb 2012 |
||
| 300 |
_a767-75 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xtoxicity |
| 650 | 0 | 4 |
_aProbucol _xpharmacology |
| 650 | 0 | 4 |
_aSynapses _xdrug effects |
| 700 | 1 | _aPeres, Kaite C | |
| 700 | 1 | _aRibeiro, Renata P | |
| 700 | 1 | _aColle, Dirleise | |
| 700 | 1 | _ados Santos, Alessandra A | |
| 700 | 1 | _aMoreira, Eduardo L G | |
| 700 | 1 | _aSouza, Diogo O G | |
| 700 | 1 | _aFigueiredo, Cláudia P | |
| 700 | 1 | _aFarina, Marcelo | |
| 773 | 0 |
_tExperimental neurology _gvol. 233 _gno. 2 _gp. 767-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2011.11.036 _zAvailable from publisher's website |
| 999 |
_c21395332 _d21395332 |
||